Toronto Dominion Bank’s Pfizer PFE Stock Holding History

Toronto Dominion Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-303,600	Closed	-$7.56M	–	2340
2025 Q4	$7.56M	Buy	+303,600	New	+$7.66M	0.01%	717
2025 Q1	–	Sell	-390,400	Closed	-$10.4M	–	1656
2024 Q4	$10.4M	Buy	+390,400	New	+$10.6M	0.02%	526
2019 Q4	–	Sell	-7,483	Closed	-$255K	–	1497
2019 Q3	$255K	Buy	+7,483	New	+$272K	﹤0.01%	1091
2018 Q2	–	Sell	-168,640	Closed	-$5.68M	–	1527
2018 Q1	$5.68M	Buy	+168,640	New	+$5.8M	0.01%	585
2016 Q2	–	Sell	-8,432	Closed	-$237K	–	1258
2016 Q1	$237K	Buy	+8,432	New	+$241K	﹤0.01%	513

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Toronto Dominion Bank's PFE Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Pfizer (PFE) stake by 47% in Q1 2026, selling an estimated $40.5M and leaving 1,713,006 shares worth $48.1M. The position accounts for 0.07% of the portfolio, ranked #245.

Toronto Dominion Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $419M in Q4 2019. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Toronto Dominion Bank held 1,713,006 shares of Pfizer worth $48.1M as of Q1 2026.
Toronto Dominion Bank sold 1,521,330 Pfizer shares in Q1 2026, an estimated $40.5M.
Pfizer made up 0.07% of Toronto Dominion Bank's portfolio in Q1 2026, its #245 holding.
Toronto Dominion Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's Pfizer position peaked at $419M in Q4 2019.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.